{{Estrogen receptor modulators/ja}}
[[Category:GABAA receptor positive allosteric modulators]]
...
14 KB (764 words) - 15:03, 4 April 2024
{{Estrogen receptor modulators}}
[[Category:GABAA receptor positive allosteric modulators]]
...
11 KB (1,560 words) - 11:49, 3 April 2024
{{Estrogen receptor modulators}}
[[Category:GABAA receptor positive allosteric modulators]]
...
12 KB (1,628 words) - 11:49, 3 April 2024
{{Estrogen receptor modulators/ja}}
{{GABAA receptor positive allosteric modulators/ja}}
...
55 KB (2,081 words) - 15:30, 20 February 2024
{{Estrogen receptor modulators}}
{{GABAA receptor positive allosteric modulators}}
...
44 KB (6,139 words) - 15:30, 20 February 2024
{{Estrogen receptor modulators}}
{{GABAA receptor positive allosteric modulators}}
...
45 KB (6,281 words) - 15:29, 20 February 2024
...、[[μ-opioid receptor/ja|μオピオイド受容体]]および[[δ-opioid receptor/ja|δオピオイド受容体]]の[[allosteric modulator/ja|アロステリックモジュレーター]]としても作用する。THCはまた、[[glycine receptor/ja|グリシン受容体]
2015年のレビューによれば、CBDとTHCの比率が高い系統の大麻を使用した場合、[[positive symptoms/ja|陽性症状]]（妄想や幻覚など）が有意に少なく、[[cognitive function/ja|認知機能]]が良好であり、精神病
...
76 KB (2,054 words) - 19:53, 7 August 2025
...d produces [[psychotropic]] effects. [[Cannabidiol|CBD]] also acts as an [[allosteric modulator]] of the [[μ-opioid receptor|μ-]] and [[δ-opioid receptor]]s. THC
...he use of high CBD-to-THC strains of cannabis showed significantly fewer [[positive symptoms]], such as delusions and hallucinations, better [[cognitive functi
...
62 KB (9,106 words) - 14:25, 4 August 2025
...d produces [[psychotropic]] effects. [[Cannabidiol|CBD]] also acts as an [[allosteric modulator]] of the [[μ-opioid receptor|μ-]] and [[δ-opioid receptor]]s. THC
...he use of high CBD-to-THC strains of cannabis showed significantly fewer [[positive symptoms]], such as delusions and hallucinations, better [[cognitive functi
...
64 KB (9,394 words) - 14:24, 4 August 2025